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Abstract. A case of alcaptonuria combined with aortic insuffi-
ciency was found in a 28-year-old male. The patient was palpitating
at admission. The daily excretion of homogentisic acid was 2.0-6.0 g.
Electrocardiography indicated atrial fibrillation and left ventricular
hypertrophy with a ST-T change and right axis deviation. Cartilage
tissues in the knee-joints showed no pigmentation. Vertebral X-ray
revealed no calcification. The patient's history disclosed a family
intermarriage in his grandparents. The patient's mother noticed the
presence of black stains on diapers in his infancy and brown pigmen-
tation on the skin and sclera in childhood. No kin had similar symp-
toms.
Alcaptonuria is a rare inherited metabolic disease characterized by the
excretion of homogentisic acid in the urine and is due to a defect in the meta-
bolism of tyrosine. Boedecker (l) was the first to scientifically describe the
alcaptonuric patient. Homogentisic aciduria arises as a consequence of the
absence of the enzyme homogentisic acid oxidase (homogentisate l, 2-dioxy-
genase) and is present almost always from birth. Hemogentisic acid is con-
sidered to be converted to maleylacetoacetic acid by the enzyme (2).
Alcaptonuria is not fatal probably because of the easy excretion of homo-
gentisic acid by urine. It is frequently noticed in infancy by stainings on the
diapers (3). Homogentisic acid in connective tissue is considered to be readily
oxidized and polymerized. This auto-oxidation polymer appears to become
irreversibly bound to collagen (4, 5). The affinity between homogentisic acid
and collagen might account for arthritis, skin pigmentation and calcification of
the spine disc often found in the disease. More than 600 cases have been
reported from 35 countries (6).
In this report, a male alcaptonuria case is described with fatal cardio-
vascular disturbance whose exact diagnosis was established at the age of 28
years. This report covers clinical and laboratory studies in addition to the
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identification and quantitation of urinary homogentisic acid.
CASE HISTORY
The patient was first admitted to Mitoyo General Hospital at the age of
23 years (November 1966) with occasional palpitation and fatigue. His past
history obtained from his mother revealed that black stains were present during
infancy on his diapers, particularly when the diapers were exposed to soap and
air. Brown pigmentations on the skin and sclera were later noted. A diastolic
murmur in the aortic valve area was found at 17 years of age. Arthralgia was
never noted. The family history disclosed an intermarriage at his grandparent's
generation. None of his relatives were reported to have simihr symptoms.
Physical examination at 28 years of age revealed: focal brown pigmen-
tation on the skin and scleras, no edema on the legs and no hepatosplenomegaly.
A diastolic murmur on aortic valve area was confirmed, and diastolic blood
pressure fell to zero. Aortic insufficiency was diagnosed. A freshly passed urine
sample was normal in appearance but rapidly turned dark-brown on addition of
sodium hydroxide solution. The urine reduced Benedict's reagent suggesting
the existence of alcaptonuria, but this was not examined further. Radiologic
examination disclosed a left ventricular enlargement but calcification typical for
ochronosis was not found.
Laboratory examination performed at f::is time disclosed: hemoglobin,
14.1 g %; white blood cell count, 5,70J p::r mm3; total serum protein, 8.6 g
% ; albumin/globulin ratio, o. ~6; urinary protein, I-plus; urinary cast, nega-
tive; antistreptolysin-O titer (ASLO), 166 Todd units; latex fixation test
(RAT), :legative; blood urea nitrogen (BUN), 15 mg %; and serum glutamic
pyruvi: tnusaminase (S-GPT). 10 Karmen units. Digitalization was instituted.
The p::ti : .. t recovered after 5 months hospitalization and was discharged on
April 7, l ~67.
In J,me 1971 an electrocardiogram revealed atrial fibrillation accompanied
with palpitation and epigastric pain. He was treated only symptomatically as
an outpatient and apparently recovered in a week.
In February 1973, dyspnea with palpitation occurred. An electrocardio-
gram revealed severe atrial fibrillation, and the patient was readmitted. His
body weight was 51 kg and his height, 165 cm. Physical examination disclosed
slight cyanosis on the skin and lips. Anemia was present on the conjunctiva.
An enlarged heart markedly deviated to left with the point of maximal impulse
in the sixth intercostal space 3 cm outside of the left midclavicular line. The
blood pressure was 120/48 mmHg. The pulse rate was 90 beats per minute
and irregular. Systolic and diastolic murmur were heard in the second and
third right intercostal space. No edema was present on the legs.
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Fig. 1. Chest roentgenograms. A, On admission (February 28, 1973); B, Five days
before death (May 16, 1973).
Fig. 2. Electrocardiograms. A, On admission (February 28, 1973); B, Five days before
death (May 16, 1973).
A chest roentgenogram (Fig. 1) taken on admission showed a markedly
enlarged heart. The white blood cell count was 5,800 per mm 3 with 59%
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polymorphonuclear leukocytes, 39% lymphocytes and 2% band forms. Labo-
ratory examination revealed a hematocrit value of 37%; hemoglobin, 13.1 g % ;
erythrocyte sedimentation rate, 9 mm in the first one hour; urinalysis, normal;
BUN, 15 mg %; serologic test for syphilis (VDRL), negative; C-reactive
protein (CRP), I-plus; ASLO, 8D Todd units; RAT, negative; total bilirubin,
0.4 mg %; S-GPT, 16 Karmen units; alkaline phosphatase, 3.2 Bodansky
units; lactate dehydrogenase (LDH), 395 Wroblewski units; serum total cho-
lesterol, 126 mg %; serum gamma globulin, 1.18 g %; and Triosorb test and
Tetrasorb test, normal. An electrocardiogram taken on admission showed atrial
fibrillation and left ventricular hypertrophy with a ST-T change and right axis
deviation (Fig. 2). A spinal X-ray examination revealed no osteochondrosis.
Right heart failure developed gradually in spite of daily administration of
0.1 mg of digitoxin. The patient complained of severe palpitation and dyspnea.
Front
Origin
2 3 4
Fig. 3. A paper chromatogram of the urine. Color was developed according to Neuber-
ger (8). Solvent system: Water saturated n-butanol with several drops of formic acid.
I and 4, authentic homogentisic acid (standards); 2, urine; 3, homogentisic acid extracted
from the urine with ethyl ether.
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An electrocardiogram taken on March 26 showed atrial fibrillation with tachy-
cardia. Liver function test disclosed serum total bilirubin of 0.7 mg % ;
S-GOT, 460 Karmen units; S-GPT, 430 Karmen units; LDH, 1,560 Wrob-
lewski units; CRP, 2-plus; proteinuria, 2-plus; and serum total protein, 7.0 g
% with a gamma globulin fraction of 1.1 g %. Administration of digitoxin and
furosemide in an oxygen tent resulted in improvement of laboratory values,
except for positive CRP. The patient showed considerable improvement in
April.
In the beginning of May, palpitation with dyspnea appeared. Physical
examination revealed hepatomegaly at 6 cm below the costal margin, and
edema on the legs and face. Laboratory examination disclosed S-GOT, 145
Karmen units; S-GPT, 210 Karmen units; LDH, 1,280 Wroblewski units;
serum total bilirubin, 4.6 mg %; CRP, 2-plus; serum total protein, 6.8 g %
with gamma globulin fraction of 1.6 g %; and proteinuria 2-plus without cast.
Electrocardiographic results were the same as in the previous examination. The
Front
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Fig. 4. Thin layer chromatogram of the urine. 1 and 4, authentic homogentisic acid
(standards); 2, urine; 3, ether extract of the urine.
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heart showed progressively severe decompensation and the patient died on May
21. Autopsy was refused by his family.
Identification and quantitation of homogentisic acid. Urinary homogentisic
acid was determined by the colorimetric method (7, 8). This method requires
a large volume of urine (25 ml), and readings were taken with an absorptio-
meter with a red filter. The method used in the present study was modified
at several points. The reaction mixture was composed of 5 ml of water solution
containing 0.1-1.0 micromole of homogentisic acid, 0.5 ml of 5% ammonium
molybdate in 5N H 2S04 and 0.5 ml of 1% monobasic potassium phosphate.
The mixture was incubated at 37°C for 30 minutes and absorbance at 700 nm
was read by a spectrophotometer. The daily excretion of homogentisic acid
was 2.0-6.0 g. For identification of homogentisic acid, descending paper chro-
matography (9) was performed on Whatman No.1 paper in a solvent of water
saturated n-butanol containing several drops of formic acid (Fig. 3). Thin
layer chromatography on a plate coated with silica gel was performed with the
same solvent to confirm the presence of urinary homogentisic acid (Fig. 4).
DISCUSSION
Alcaptonuria is usually first suspected by dark diaper stainings, and rarely
by ochronosis and arthritis. The clinical diagnosis is usually made from a
combination of arthritis, ochronotic pigmentation and urine which darkens on
addition of strong alkali (10). In this case the characteristic brown pigmenta-
tion on the skin and sclera and the dark brown urine were found but not
arthritis. The arthritis in this disease usually begins at middle age (10).
O'Brien, La Du and Bunim (6) reviewed the disease based on analysis of 604
cases reported from 35 countries. They estimated the average patient affected
by ochronotic arthropathy was 41 years of age and was more likely to be a
male than a female. Our patient was younger than average and arthritis was
absent at 29 years of age.
The diagnosis should be established on the basis of urinary homogentisic
acid identified by appropriate methods (11). Thin layer chromatography and
paper chromatography were employed in this study. Quantitative analysis of
urinary homogentisate was performed on a smaller scale than by the original
method. The large amounts of acid excretion (as much as 2.6-6.0 g per day)
are consistent with the values reported in the literature (8, 12).
A review of the reported cases of the disease disclosed that correct diagnosis
was made in 252 cases but was initially missed in 97 other cases (6). The
review also stated that one patient first noted dark urine at the age of 93 and
that a diagnosis was not made in 28 patients until postmortem. The mother of
the present patient noticed brown staining during the patient's infancy but a
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physician was not consulted on this condition until he had palpitation at 23
years of age, probably because alcaptonuria per se is benign and without obvious
symptoms. A definitive diagnosis was finally established at 28 years of age.
O'Brien, La Du and Bunin (6) reported"cardiovascular lesions of ochronosis
including diffuse bluish pigmentation of the heart valves, endocardium and
intima of the aorta. Discoloration was especially prominent at the base of the
mitral and aortic valves and annulus fibrosus. The edges of cusps were
roughened, fused for 1 to 2 mm at the base and minimally calcified. These
changes were found in only 2 of 13 patients below 50 years of age. These
investigators also stated that although striking pigmentation of arteriosclerotic
plagues was seen, the alcaptonuria did not seem to contribute significantly to
the arteriosclerosis or cause clinically discernible cardiac disease. We could not
explain the aortic insufficiency in our patient, since he previously did not show
evidence of rheumatic fever, sepsis, syphilis or congenital valvular disease.
Richman, Dalman and Grep (13) showed that the liver function indices
could be deranged in congestive heart failure (13). They examined the liver
function in 175 patients with right-side congestive heart failure due to various
causes and found that four-fifths of patients with elevated levels of S-GOT
indicated measures between 40 and 80 Karmen units, but that the remainder
had values as high as 1,250 Karmen units, and that the highest value of S-GPT
was 530 Karmen units. Therefore, the elevation of S-GOT and S-GPT in this
patient might be due to aortic insufficiency, since liver function indices returned
to the normal range when the congestive condition was improved.
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